Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tanya Trippett, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Arnold Palmer Hospital for Children/md Anderson Cancer Center Orlando
Orlando, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- John Hopkins Medical Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Children'S Mercy Hospital & Clinics
Kansas City, Missouri, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Pennsylvania State University College of Medicine
Hershey, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Feb 2011
- Primary completion
- 8 Dec 2020
- Completion
- 8 Dec 2020
- Last update posted
- 18 Nov 2021
- Registered enrollment
- 27
- Registry id
- NCT01294670
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.